High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factors.

Thirty-one consecutive patients with relapsed or refractory GCT received an HDT schedule including carboplatin, the dose of which was adjusted to measured glomerular filtration rate. There was one HDT-associated death (3%), due to acute renal failure. The 3-year probability of overall and disease-fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyttelton, M. P., Newlands, E. S., Giles, C., Bower, M., Guimaraes, A., O'Reilly, S., Rustin, G. J., Samson, D., Kanfer, E. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150058/
https://www.ncbi.nlm.nih.gov/pubmed/9635847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150058/
https://www.ncbi.nlm.nih.gov/pubmed/9635847

Ejemplares similares